At a Glance
Cambridge Innovation Capital is a venture capital firm based in Cambridge, United Kingdom founded in 2013. We are driven by people and ideas. As a team, we have a passion for science and its potential to drive change. Through our expertise and our position in one of the country's most powerful science and technology ecosystems, we're able to identify and support the most promising entrepreneurs in knowledge intensive businesses and help them achieve their vision. The firm focuses on Pre-Seed, Seed, Series A, Series B+ investments across sectors including Aerospace & Defense, Digital Health, Other, Consumer, Fintech. The firm manages £350M in assets under management. Notable portfolio companies include Healx, CMR Surgical, Isogenica and Dovetailed. Focuses on deep tech companies spinning out of the University of Cambridge and other leading research institutions.
“Focuses on deep tech companies spinning out of the University of Cambridge and other leading research institutions.”
Cambridge Innovation Capital primarily invests at the Pre-Seed, Seed, Series A, Series B+ stages. This means they focus on companies that are at the earliest idea or prototype phase.
Cambridge Innovation Capital is headquartered in Cambridge, UK. Many of their portfolio companies are also based in this region, though they invest across geographies.
Cambridge Innovation Capital focuses on investments in Aerospace & Defense, Digital Health, Other, Consumer, Fintech. Their portfolio reflects deep expertise and networks within these sectors.
Cambridge Innovation Capital's typical investment check size ranges from $. to $.. Actual amounts may vary based on the stage, sector, and specific opportunity.
Cambridge Innovation Capital manages approximately £350M in assets under management (AUM) across their funds.
